Evaluates valbenazine effects on quality of life in tardive dyskinesia, indicating significant improvements.
To evaluate the effects of once-daily valbenazine on quality of life (QoL) in patients with tardive dyskinesia (TD).
No takes yet. Share an insight, caveat, or question.
Dunayevich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: